Therapy News and Research

RSS

Many transgender individuals lack knowledge and access to fertility options, survey finds

Nearly one-fourth of transgender individuals in Toronto, Canada, regard their own fertility as important, but most lack knowledge regarding and access to reproductive options, a new survey finds. Results of the survey will be presented Sunday at the Endocrine Society's 99th annual meeting in Orlando, Fla.

3 Apr 2017

‘The Agony of Hives’: WAO to offer complementary live webinar on chronic urticaria

World Allergy Organization will offer a complementary live webinar, “The Agony of Hives”, on April 4, beginning at 13:30:00 Greenwich Mean Time, for World Allergy Week 2017, which will begin on April 2.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.

2 Apr 2017

Preference for evening activity in type 2 diabetes patients linked to greater depression symptoms

People with type 2 diabetes who are "night owls" and prefer the evening for activity report having more symptoms of depression than those who are early to bed and early to rise, regardless of the quality of their sleep, a new study finds.

2 Apr 2017

Cow's milk decreases the body's ability to absorb oral thyroid hormone medication

Taking the common oral thyroid hormone medication levothyroxine with a glass of cow's milk significantly decreases the body's ability to absorb the drug, a preliminary study finds. Results will be presented Sunday at ENDO 2017, the Endocrine Society's 99th annual meeting in Orlando, Fla.

2 Apr 2017

ACR outlines health policy priorities to improve access to arthritis care and treatments

The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care and treatments for the 54 million Americans living with arthritis and other rheumatologic diseases.

31 Mar 2017

Study provides new understanding of molecular mechanisms of HPV-induced tumors

The incidence of human papillomavirus (HPV)-associated (HPV+) head and neck squamous cell carcinoma (HNSCC) of the oropharynx has dramatically increased over the last decade and is now more frequently diagnosed than uterine cervical cancer in the United States.

31 Mar 2017

USAHS experts to present key occupational therapy research at AOTA Annual Conference

University of St. Augustine Health Sciences, a leading graduate institution that emphasizes health science education through innovative classroom education, is proud to announce that several faculty members will be presenting key research at the American Occupational Therapy Association Annual Conference & Centennial Celebration in Philadelphia, March 30 - April 2.

31 Mar 2017

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Novocure announced today results from the second cohort of its phase 2 pilot PANOVA trial studying Tumor Treating Fields (TTFields) in combination with nab-paclitaxel and gemcitabine for the treatment of advanced pancreatic cancer.

31 Mar 2017

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Novocure announced today results from its phase 2 pilot INNOVATE trial studying Tumor Treating Fields (TTFields) in combination with weekly paclitaxel for the treatment of recurrent ovarian cancer.

31 Mar 2017

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.

31 Mar 2017

New therapy proves effective in reducing symptoms of treatment-resistant depression

In the largest study ever conducted with patients experiencing chronic and severe depression, researchers led by Dr. Scott Aaronson, Director of Clinical Research at Sheppard Pratt Health System have found that an implantable vagus nerve stimulation device paired with antidepressant treatment (which could include medications, psychotherapy, or electroconvulsive therapy proves effective in reducing symptoms among patients with treatment-resistant depression.

31 Mar 2017

New report outlines strategies for regenerating retinal ganglion cells

A new report gives recommendations for regenerating retinal ganglion cells (RGCs), crucial neurons in the back of the eye that carry visual information to the brain.

31 Mar 2017

Discovery of new genes linked to Erdheim-Chester disease provides hope for improving diagnoses

National Human Genome Research Institute researchers have identified new genes associated with the Erdheim-Chester disease and some possible new therapies. Findings on this ultra-rare disease, found in approximately 600 people in the world, were published in Blood Advances.

31 Mar 2017

Researchers find antibody to be effective against radiation-induced fibrosis

Radiation therapy is part of the treatment regimen for about two thirds of cancer patients today. Radiotherapy is well tolerated in most cases, but it can also lead to damage in healthy tissues that are also irradiated.

31 Mar 2017

GHIT Fund invests in phase 3 clinical trial for pediatric formulation of ‘snail fever’ drug

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced 11 new investments totaling US$23 million that could help deliver a range of new innovative therapies for a host of debilitating conditions.

31 Mar 2017

Common neurological diseases pose serious annual financial burden for the U.S.

The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.

30 Mar 2017

Novel Research Grants bring new insight to complexities of lupus

The Lupus Research Alliance announced today the Novel Research Grant Class of 2017. The Lupus Research Alliance Novel Research Grants, the proven platform for innovation, make discovery and scientific progress possible.

30 Mar 2017

New imaging tool that spots lung infections could help prevent antibiotic overuse

A new imaging tool that rapidly diagnoses bacterial lung infections could help prevent unnecessary use of antibiotics in intensive care units.

30 Mar 2017

Therapy News and Research

Many transgender individuals lack knowledge and access to fertility options, survey finds

‘The Agony of Hives’: WAO to offer complementary live webinar on chronic urticaria

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Preference for evening activity in type 2 diabetes patients linked to greater depression symptoms

Cow's milk decreases the body's ability to absorb oral thyroid hormone medication

ACR outlines health policy priorities to improve access to arthritis care and treatments

Study provides new understanding of molecular mechanisms of HPV-induced tumors

USAHS experts to present key occupational therapy research at AOTA Annual Conference

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Case Western Reserve and Q2 Pharma partner to develop antivirulence agents that disarm superbugs

New therapy proves effective in reducing symptoms of treatment-resistant depression

New report outlines strategies for regenerating retinal ganglion cells

Discovery of new genes linked to Erdheim-Chester disease provides hope for improving diagnoses

Researchers find antibody to be effective against radiation-induced fibrosis

GHIT Fund invests in phase 3 clinical trial for pediatric formulation of ‘snail fever’ drug

Common neurological diseases pose serious annual financial burden for the U.S.

Novel Research Grants bring new insight to complexities of lupus

New imaging tool that spots lung infections could help prevent antibiotic overuse

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News